Literature DB >> 8086506

Study of platelet-associated immunoglobulins of IgG, IgM, IgA, and IgE classes and platelet kinetics in 33 patients with idiopathic thrombocytopenic purpura.

M R Movahed Shariat Panahi1, S Le Blanc, O Schober, R Coldewey, H Deicher.   

Abstract

The role of platelet-associated immunoglobulins (PAIg) of four different immunoglobulin classes--IgM, IgG, IgA, and IgE--and their relation to platelet count and platelet kinetics was studied in 33 patients with idiopathic thrombocytopenic purpura (ITP). During the course of 1 year, repeated determinations of PAIg were made. The results indicate that PAIgG, PAIgM, and PAIgA are present in all ITP patients, and that autoantibodies of all three Ig classes show highly significant correlations to the platelet counts (p < 0.0001). Double logarithmic negative correlations have been found between PAIgG and platelet count (r = -0.71), PAIgM and platelet count (r = -0.84), and PAIgA and platelet count (r = -0.79). Statistical analyses using partial correlation and multiple regression methods showed that PAIgM is predominantly related to the platelet count, whereas PAIgG and PAIgA are only of secondary importance. Accordingly, a relation of PAIgM (and PAIgA) to increased liver destruction of platelets was found in kinetic studies using 111indium-labeled platelets. Taken together, these results suggest a predominant role of PAIgM in the pathogenesis of ITP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086506     DOI: 10.1007/bf01695692

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  28 in total

1.  Sites of platelet destruction in idiopathic thrombocytopenic purpura.

Authors:  R H Aster; W R Keene
Journal:  Br J Haematol       Date:  1969 Jan-Feb       Impact factor: 6.998

2.  Intravenous high-dose IgG therapy induced alterations of spleen lymphocyte IgM secretion and T cell subsets in patients with idiopathic thrombocytopenic purpura.

Authors:  J C Bordet; G Follea; E Carosella; M Dechavanne
Journal:  Thromb Res       Date:  1987-07-15       Impact factor: 3.944

3.  Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ.

Authors:  A du P Heyns; P N Badenhorst; M G Lötter; H Pieters; P Wessels; H F Kotzé
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

4.  Simultaneous enzymo-immunologic assays of platelet associated IgG, IgM and C3. A useful tool in assessment of immune thrombocytopenias.

Authors:  G Follea; B Mandrand; M Dechavanne
Journal:  Thromb Res       Date:  1982-05-15       Impact factor: 3.944

5.  Enzyme linked immunoassay for the detection of platelet associated IgG.

Authors:  U M Hegde; D K Powell; A Bowes; E C Gordon-Smith
Journal:  Br J Haematol       Date:  1981-05       Impact factor: 6.998

6.  Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3c in chronic idiopathic autoimmune thrombocytopenia: relation to the sequestration pattern of 111indium labelled platelets.

Authors:  S Panzer; H Niessner; K Lechner; R Dudczak; U Jäger; W R Mayr
Journal:  Scand J Haematol       Date:  1986-08

7.  Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states.

Authors:  C Mueller-Eckhardt; G Mueller-Eckhardt; W Kayser; R M Voss; J Wegner; E Küenzlen
Journal:  Br J Haematol       Date:  1982-09       Impact factor: 6.998

8.  In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura.

Authors:  T Tsubakio; Y Kurata; Y Kanayama; T Yonezawa; S Tarui; T Kitani
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

9.  Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia.

Authors:  L M Kernoff; K C Blake; D Shackleton
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

10.  Beneficial effect of intravenous gammaglobulin in a patient with complement-mediated autoimmune thrombocytopenia due to IgM-anti-platelet antibodies.

Authors:  A Brand; M Witvliet; F H Claas; J G Eernisse
Journal:  Br J Haematol       Date:  1988-08       Impact factor: 6.998

View more
  1 in total

1.  Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B.

Authors:  Majed A Refaai; Jessie Carter; Kelly F Henrichs; Donna C Davidson; Stephen J Pollock; Ann E Casey; Sherry L Spinelli; Richard P Phipps; Charles W Francis; Neil Blumberg
Journal:  Transfusion       Date:  2012-05-25       Impact factor: 3.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.